These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20207820)

  • 1. Comparison of parathyroid hormone and G-CSF treatment after myocardial infarction on perfusion and stem cell homing.
    Huber BC; Fischer R; Brunner S; Groebner M; Rischpler C; Segeth A; Zaruba MM; Wollenweber T; Hacker M; Franz WM
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1466-71. PubMed ID: 20207820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.
    Brunner S; Huber BC; Fischer R; Groebner M; Hacker M; David R; Zaruba MM; Vallaster M; Rischpler C; Wilke A; Gerbitz A; Franz WM
    Exp Hematol; 2008 Jun; 36(6):695-702. PubMed ID: 18346841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
    Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
    Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardioprotective effects of parathyroid hormone are independent of endogenous granulocyte-colony stimulating factor release.
    Brunner S; Weinberger T; Huber BC; Segeth A; Zaruba MM; Theiss HD; Assmann G; Herbach N; Wanke R; Mueller-Hoecker J; Franz WM
    Cardiovasc Res; 2012 Feb; 93(2):330-9. PubMed ID: 22080594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with granulocyte-colony stimulating factor in patients with acute myocardial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusion.
    Kuethe F; Krack A; Fritzenwanger M; Herzau M; Opfermann T; Pachmann K; Sayer HG; Werner GS; Gottschild D; Figulla HR
    Pharmazie; 2006 Nov; 61(11):957-61. PubMed ID: 17152990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration of bone marrow-derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarction.
    Brunner S; Huber BC; Weinberger T; Vallaster M; Wollenweber T; Gerbitz A; Hacker M; Franz WM
    J Cell Mol Med; 2012 Jan; 16(1):152-9. PubMed ID: 21362129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.
    Brunner S; Winogradow J; Huber BC; Zaruba MM; Fischer R; David R; Assmann G; Herbach N; Wanke R; Mueller-Hoecker J; Franz WM
    FASEB J; 2009 Feb; 23(2):351-61. PubMed ID: 18827024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart.
    Huber BC; Brunner S; Segeth A; Nathan P; Fischer R; Zaruba MM; Vallaster M; Theiss HD; David R; Gerbitz A; Franz WM
    Cardiovasc Res; 2011 Jun; 90(3):529-37. PubMed ID: 21245057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of cardiac hypertrophy by G-CSF is associated with enhanced migration of bone marrow-derived cells.
    Huber BC; Beetz NL; Laskowski A; Ziegler T; Grabmaier U; Kupatt C; Herbach N; Wanke R; Franz WM; Massberg S; Brunner S
    J Cell Mol Med; 2015 May; 19(5):1033-41. PubMed ID: 25754690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
    Zaruba MM; Huber BC; Brunner S; Deindl E; David R; Fischer R; Assmann G; Herbach N; Grundmann S; Wanke R; Mueller-Hoecker J; Franz WM
    Cardiovasc Res; 2008 Mar; 77(4):722-31. PubMed ID: 18055578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial G-CSF/AMD3100 treatment in cardiac repair after myocardial infarction.
    Rüder C; Haase T; Krost A; Langwieser N; Peter J; Kamann S; Zohlnhöfer D
    PLoS One; 2014; 9(8):e104644. PubMed ID: 25121738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
    Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
    Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
    Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
    JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
    Theiss HD; Vallaster M; Rischpler C; Krieg L; Zaruba MM; Brunner S; Vanchev Y; Fischer R; Gröbner M; Huber B; Wollenweber T; Assmann G; Mueller-Hoecker J; Hacker M; Franz WM
    Stem Cell Res; 2011 Nov; 7(3):244-55. PubMed ID: 21752744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization of mesenchymal stem cells by granulocyte colony-stimulating factor in rats with acute myocardial infarction.
    Cheng Z; Liu X; Ou L; Zhou X; Liu Y; Jia X; Zhang J; Li Y; Kong D
    Cardiovasc Drugs Ther; 2008 Oct; 22(5):363-71. PubMed ID: 18461431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis.
    Deindl E; Zaruba MM; Brunner S; Huber B; Mehl U; Assmann G; Hoefer IE; Mueller-Hoecker J; Franz WM
    FASEB J; 2006 May; 20(7):956-8. PubMed ID: 16571777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction.
    Takano H; Ohtsuka M; Akazawa H; Toko H; Harada M; Hasegawa H; Nagai T; Komuro I
    Curr Pharm Des; 2003; 9(14):1121-7. PubMed ID: 12769752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells.
    Yau TM; Tomita S; Weisel RD; Jia ZQ; Tumiati LC; Mickle DA; Li RK
    Ann Thorac Surg; 2003 Jan; 75(1):169-76; discussion 176-7. PubMed ID: 12537212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction.
    Delgaudine M; Gothot A; Beguin Y
    Cytotherapy; 2010 Nov; 12(7):909-18. PubMed ID: 20230223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.